These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12116277)

  • 1. A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.
    Antiñolo G; Marcos I; Fernández RM; Romero M; Borrego S
    Am J Med Genet; 2002 Jun; 110(1):85-7. PubMed ID: 12116277
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET.
    Kasprzak L; Nolet S; Gaboury L; Pavia C; Villabona C; Rivera-Fillat F; Oriola J; Foulkes WD
    J Med Genet; 2001 Nov; 38(11):784-7. PubMed ID: 11732489
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel somatic mutation in the RET proto-oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation.
    Miyauchi A; Egawa S; Futami H; Kuma K; Obara T; Yamaguchi K
    Jpn J Cancer Res; 1997 Jun; 88(6):527-31. PubMed ID: 9263528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma.
    Marsh DJ; Andrew SD; Learoyd DL; Pojer R; Eng C; Robinson BG
    Hum Mutat; 1998; Suppl 1():S3-4. PubMed ID: 9452023
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
    Eng C; Smith DP; Mulligan LM; Healey CS; Zvelebil MJ; Stonehouse TJ; Ponder MA; Jackson CE; Waterfield MD; Ponder BA
    Oncogene; 1995 Feb; 10(3):509-13. PubMed ID: 7845675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.
    Marsh DJ; Learoyd DL; Andrew SD; Krishnan L; Pojer R; Richardson AL; Delbridge L; Eng C; Robinson BG
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):249-57. PubMed ID: 8729519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy.
    Dang GT; Cote GJ; Schultz PN; Khorana S; Decker RA; Gagel RF
    Mol Cell Probes; 1999 Feb; 13(1):77-9. PubMed ID: 10024437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation.
    Gimm O; Neuberg DS; Marsh DJ; Dahia PL; Hoang-Vu C; Raue F; Hinze R; Dralle H; Eng C
    Oncogene; 1999 Feb; 18(6):1369-73. PubMed ID: 10022819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
    Matias-Guiu X; Lagarda E; Calaf M; Azpiroz A; De Leiva A; Prat J; Baiget M
    Hum Mutat; 1997; 9(5):476. PubMed ID: 9143934
    [No Abstract]   [Full Text] [Related]  

  • 10. A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.
    Fattoruso O; Quadro L; Libroia A; Verga U; Lupoli G; Cascone E; Colantuoni V
    Hum Mutat; 1998; Suppl 1():S167-71. PubMed ID: 9452077
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral renal agenesis in a family with medullary thyroid carcinoma.
    Loré F; Di Cairano G; Talidis F
    N Engl J Med; 2000 Apr; 342(16):1218-9. PubMed ID: 10777380
    [No Abstract]   [Full Text] [Related]  

  • 13. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M; Weinhüsel A; Niederle B; Haas OA
    Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new identified germline mutation of the RET proto-oncogene responsible for familial medullary thyroid carcinoma in co-existence with a hyperfunctioning autonomous nodule.
    Maschek W; Pichler R; Rieger R; Weinhäusel A; Berg J
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):823. PubMed ID: 12072055
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC.
    Kitamura Y; Goodfellow PJ; Shimizu K; Nagahama M; Ito K; Kitagawa W; Akasu H; Takami H; Tanaka S; Wells SA
    Oncogene; 1997 Jun; 14(25):3103-6. PubMed ID: 9223675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of medullary carcinoma of the thyroid.
    Favia G; Lumachi F
    Tumori; 2001; 87(4):S49-51. PubMed ID: 11693822
    [No Abstract]   [Full Text] [Related]  

  • 17. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line.
    Carlomagno F; Salvatore D; Santoro M; de Franciscis V; Quadro L; Panariello L; Colantuoni V; Fusco A
    Biochem Biophys Res Commun; 1995 Feb; 207(3):1022-8. PubMed ID: 7864888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease.
    Sasaki Y; Shimotake T; Go S; Iwai N
    Eur J Surg; 2001 Jun; 167(6):467-9. PubMed ID: 11471675
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial review of "Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 RET germline mutations".
    Wilhelm S; Prinz RA
    Surgery; 2004 Apr; 135(4):447-8. PubMed ID: 15041969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.